[Congressional Record Volume 170, Number 115 (Thursday, July 11, 2024)]
[Senate]
[Page S4765]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 2443. Mr. RUBIO (for himself and Ms. Warren) submitted an 
amendment intended to be proposed by him to the bill S. 4638, to 
authorize appropriations for fiscal year 2025 for military activities 
of the Department of Defense, for military construction, and for 
defense activities of the Department of Energy, to prescribe military 
personnel strengths for such fiscal year, and for other purposes; which 
was ordered to lie on the table; as follows:

       At the appropriate place in subtitle H of title X, insert 
     the following:

     SEC. 10___. MODIFICATION OF RULES OF ORIGIN FOR 
                   PHARMACEUTICAL PRODUCTS.

       (a) Trade Agreements.--Section 308(4)(B) of the Trade 
     Agreements Act of 1979 (19 U.S.C. 2518(4)(B)) is amended--
       (1) in clause (i), by striking ``instrumentality, or'' and 
     inserting ``instrumentality,'';
       (2) in clause (ii), by inserting ``, other than an active 
     pharmaceutical ingredient,'' after ``part of materials''; and
       (3) by striking the period at the end and inserting ``, or 
     (iii) in the case of an article which consists of an active 
     pharmaceutical ingredient, the pharmaceutical ingredient is 
     wholly the growth, product, or manufacture of that country or 
     instrumentality.''.
       (b) Federal Acquisition Regulation.--Not later than 180 
     days after the date of the enactment of this Act, the 
     President shall prescribe regulations to update sections 
     52.225-5 and 25.003 of title 48, Code of Federal Regulations 
     (or successor regulations) to be consistent with rules of 
     origin determinations for active pharmaceutical ingredients 
     made under section 308(4)(B) of the Trade Agreements Act of 
     1979 (19 U.S.C. 2518(4)(B)), as amended by subsection (a).
                                 ______